Loading...
Back to narrative

Janpeo updated the narrative for RJF

Laboratorio Reig Jofre will experience a revenue boost of 8.51%

RJF logo
RJF
Janpeo
Not Invested
Published 03 Nov 2025
2 viewsusers have viewed this narrative update

Update shared on 09 Nov 2025

Fair value Decreased 26%
Next
07 May
€2.62
Janpeo's Fair Value
€3.29
20.4% undervalued intrinsic discount
Loading
1Y
-12.1%
7D
-1.5%
  • Resultados 9M con beneficio -76 %, pero dentro de lo esperado.
  • Confirmación de que la parada industrial termina en 2026, por tanto la debilidad es transitoria.
  • Ratio deuda/EBITDA 2,1×, totalmente manejable.
  • Perspectiva de mejora de márgenes a partir del 2S 2026.

Have other thoughts on Laboratorio Reig Jofre?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

The user Janpeo holds no position in BME:RJF. Simply Wall St has no position in any of the companies mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The author of this narrative is not affiliated with, nor authorised by Simply Wall St as a sub-authorised representative. This narrative is general in nature and explores scenarios and estimates created by the author. The narrative does not reflect the opinions of Simply Wall St, and the views expressed are the opinion of the author alone, acting on their own behalf. These scenarios are not indicative of the company's future performance and are exploratory in the ideas they cover. The fair value estimates are estimations only, and does not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that the author's analysis may not factor in the latest price-sensitive company announcements or qualitative material.